Disease and Bio-Security · Summer Term

Drug Discovery and Development

Exploring the rigorous process of testing new medicines from laboratory to clinical trials.

About This Topic

Drug discovery and development traces a multi-stage process from lab identification of compounds to market approval. Year 11 students examine pre-clinical testing on cells and animals for toxicity, then human clinical trials: Phase 1 tests safety in small groups, Phase 2 assesses dosage and efficacy, and Phase 3 confirms benefits in thousands via double-blind methods. These randomised, controlled trials, where neither participants nor researchers know treatment allocations, reduce bias and establish reliability.

This content supports GCSE Biology standards in Infection and Response and Drugs and Medicine, linking to bio-security through development of antimicrobials against resistant infections. Key questions probe the gold standard of double-blind trials, ethical challenges like informed consent and vulnerability in trials, and trade-offs in emergencies such as rapid vaccine rollouts versus thorough safety checks. Students build skills in evaluating evidence and societal impacts.

Active learning excels with this topic because abstract timelines and ethics become concrete through role-plays, debates, and case analyses. Students internalise the decade-long process and decision-making complexities, improving retention and critical application over passive note-taking.

Learning Objectives

• Analyze the stages of drug discovery from initial research to post-market surveillance.
• Evaluate the ethical considerations and potential biases present in different phases of clinical trials.
• Compare the design and purpose of Phase 1, Phase 2, and Phase 3 clinical trials.
• Explain the scientific rationale behind using placebo-controlled, double-blind trials to assess drug efficacy and safety.
• Critique the balance between the urgency for new drug approval in public health emergencies and the necessity of rigorous safety testing.

Before You Start

Cells as the Basic Units of Life

Why: Understanding cell structure and function is foundational for comprehending how drugs interact with biological systems at a cellular level during pre-clinical testing.

Human Body Systems and Their Functions

Why: Knowledge of how different organ systems work is necessary to understand drug absorption, distribution, metabolism, and excretion, as well as potential side effects tested in clinical trials.

Introduction to Microorganisms and Disease

Why: This topic provides context for why new drugs, particularly antibiotics and antivirals, are developed and the importance of combating infectious diseases.

Key Vocabulary

Pre-clinical testing	Laboratory and animal studies conducted before human trials to assess a drug's safety and potential efficacy. This stage identifies potential toxicity and determines safe starting doses for human testing.
Clinical trials	Research studies involving human volunteers to evaluate the safety and effectiveness of new drugs or treatments. These trials are conducted in distinct phases, each with specific objectives.
Placebo	An inactive substance or treatment that looks like the real drug but has no therapeutic effect. Placebos are used in clinical trials to control for psychological effects and establish a baseline for comparison.
Double-blind trial	A research study where neither the participants nor the researchers administering the treatment know who is receiving the active drug and who is receiving the placebo. This design minimizes bias in reporting results.
Efficacy	The ability of a drug to produce the desired therapeutic effect under ideal or controlled conditions. It measures how well a drug works in clinical trials.

Active Learning Ideas

Role-Play: Mock Clinical Trial

Assign roles as patients, researchers, and regulators. Groups randomise drug or placebo assignments blindly, simulate data collection over two rounds, then reveal allocations to analyse outcomes. Conclude with a debrief on bias reduction. Follow up by having groups present findings to the class.

⏱ 50 min·Small Groups

Generate mission

Timeline Challenge: Development Stages

Provide cards with key events from discovery to approval. In pairs, sequence them on posters, adding notes on duration, costs, and failures. Pairs then compare timelines and discuss emergency accelerations like COVID vaccines.

⏱ 30 min·Pairs

Generate mission

Formal Debate: Ethics in Trials

Divide class into teams to argue for or against rapid drug approval in pandemics. Provide evidence packs on past cases. Teams prepare 3-minute speeches, followed by whole-class voting and reflection on balanced views.

⏱ 45 min·Whole Class

Generate mission

Case Study Analysis: Antibiotic Resistance Drug

Small groups receive a real-world case file on a new drug's journey. Chart successes, failures, and ethical decisions. Groups share via gallery walk, noting common trial pitfalls.

⏱ 40 min·Small Groups

Generate mission

Real-World Connections

The development of the COVID-19 vaccines by companies like Pfizer and AstraZeneca involved rapid progression through pre-clinical and clinical trial phases, highlighting the challenges of balancing speed with safety during a global pandemic.

Patients participating in trials for new cancer therapies at institutions like the Royal Marsden Hospital in London provide crucial data that informs treatment guidelines and regulatory approvals by agencies such as the MHRA.

Watch Out for These Misconceptions

Common Misconception

Drugs are ready for humans right after animal tests.

What to Teach Instead

Human biology differs, so clinical phases detect unique side effects. Role-playing trials lets students simulate these differences, compare animal and human data, and see why phased testing builds confidence in safety.

Common Misconception

Double-blind trials waste time and are not needed.

What to Teach Instead

Blinding prevents bias in reporting outcomes. Mock trial activities demonstrate this: students witness skewed results without blinding, then correct them, grasping its role in reliable evidence.

Common Misconception

Drug development takes only months.

What to Teach Instead

Most take 10-15 years due to iterative testing. Timeline sorts and case studies visualise delays from failures, helping students appreciate the rigour over quick assumptions.

Assessment Ideas

Discussion Prompt

Pose the question: 'Why is a double-blind trial considered the gold standard for testing new medicines?' Ask students to identify at least two reasons and explain how these reasons help ensure reliable results, referencing potential sources of bias that are avoided.

Quick Check

Present students with a scenario describing a hypothetical drug trial. Ask them to identify which phase the trial is likely in (Phase 1, 2, or 3) and justify their answer by referring to the number of participants and the primary goal of the trial described.

Exit Ticket

On a small card, ask students to write one ethical dilemma that might arise during human drug testing and one strategy that researchers use to address it. For example, they might mention informed consent and the process of obtaining it.

Frequently Asked Questions

What makes double-blind trials the gold standard?

Double-blind trials minimise bias by keeping treatment allocations secret from participants and researchers, ensuring objective data on efficacy and safety. In GCSE Biology, students learn this through Phase 3 examples, where placebos control for placebo effects and observer influence, leading to trustworthy results approved by regulators like the MHRA.

What ethical dilemmas arise in drug testing on humans?

Key issues include informed consent, especially for vulnerable groups, equitable access, and weighing benefits against risks. Students explore cases where withholding treatment harms controls, balanced by oversight from ethics committees. Active discussions reveal how science navigates these to protect participants while advancing medicine.

How can active learning help teach drug discovery?

Role-plays of trials and ethical debates make the abstract process experiential: students embody biases, negotiate consents, and timeline real cases, deepening understanding of stages and decisions. Collaborative analysis of failures builds evidence evaluation skills, far beyond lectures, and fosters retention through peer teaching and reflection.

How to balance fast drug approval in emergencies with safety?

Emergencies like pandemics use adaptive trials and rolling reviews for speed, but maintain core phases with interim data checks. UK examples like COVID vaccines show parallel testing and global data sharing. Teach via debates: students weigh risks, learning regulators prioritise lives without skipping validation.